Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of Its Investigational Oral Obesity Candidates at the ADA 85th Scientific Sessions
Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof…
Hyundai Motor Group Tops Rankings in 2025 IIHS Top Safety Awards
Hyundai Motor Group Earns 15 IIHS Top Safety Awards Across Hyundai, Kia…
Automobili Lamborghini awarded with the Randstad Employer Brand 2025
The company tops the automotive sector rankings as the most attractive employer…
Enzon and Viskase Enter into Merger Agreement
Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of…
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
June 20, 2025 19:30 ET | Source: Structure Therapeutics Inc. SAN FRANCISCO,…
Treatment.com AI Grants Stock Option and RSUs
June 20, 2025 17:26 ET | Source: Treatment.com AI Inc. VANCOUVER, British…
Oper8 Global Group Receives Frost & Sullivan’s 2025 European Customer Value Leadership Recognition for Excellence in Edge Data Center Solutions
This award recognizes Oper8 Global Group's innovation in edge data center for…
Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings…
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals…
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc.…